Cardiovascular Safety and Benefits of PDE-5 Inhibition in Women with Female Sexual Dysfunction (FSD): Summary of Findings from Clinical Trials of PDE-5 Inhibition in Women

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Cardiovascular Safety and Benefits of PDE-5 Inhibition in Women with Female Sexual Dysfunction (FSD): Summary of Findings from Clinical Trials of PDE-5 Inhibition in Women

By "Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023. FEATURING Irwin Goldstein

62 views

July 18, 2023

Speaker Name and Title: Irwin Goldstein MD
The Princeton 4 meeting was sponsored by an ...
read more ↘ unrestricted grant from Sanofi.
Sanofi was not involved in choosing the content or speakers for the meeting.

Affiliation of the speaker:
San Diego Sexual Medicine
Alvarado Hospital, San Diego, CA
University of California at San Diego
Sexual Medicine Reviews
The Journal of Sexual Medicine
International Journal of Impotence Research

Title of the speaker’s talk: “Cardiovascular safety and benefits of PDE-5 inhibition in women with female sexual dysfunction (FSD). (Summary of findings from clinical trials of PDE-5 inhibition in women). “

Financial disclosure/Conflict of Interest:
Adamo Bioscience - they do novel pharmacologic drugs for HSTD
Cynosure - CO2 fractional laser work
↖ read less

Comments 0